Tempus AI (NASDAQ:TEM) Stock Price Down 3.3% - Time to Sell?

Key Points

• Tempus AI's stock price decreased by 3.3%, closing at $62.38, with trading volume down 74% from its average.
• Analysts have a consensus rating of "Moderate Buy" for Tempus AI, with price targets ranging from $60.00 to $75.00.
• Despite the recent stock decline, Tempus AI reported a significant 75.4% year-over-year increase in quarterly revenue, amounting to $255.74 million.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price traded down 3.3% during mid-day trading on Monday . The stock traded as low as $62.72 and last traded at $62.38. 3,334,255 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 12,641,020 shares. The stock had previously closed at $64.49.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Piper Sandler raised their target price on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Wednesday, May 7th. BTIG Research started coverage on shares of Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price objective on the stock. Morgan Stanley boosted their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Finally, Guggenheim boosted their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $65.09.

Tempus AI Stock Down 4.1%

The company has a market cap of $10.71 billion and a P/E ratio of -7.93. The firm's 50 day moving average price is $62.80 and its two-hundred day moving average price is $56.78. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The company had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. The company's quarterly revenue was up 75.4% on a year-over-year basis. Equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling

In other Tempus AI news, EVP Erik Phelps sold 51,317 shares of the company's stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the sale, the executive vice president directly owned 97,779 shares of the company's stock, valued at $7,094,844.24. This represents a 34.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO James William Rogers sold 23,121 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $63.27, for a total transaction of $1,462,865.67. Following the completion of the sale, the chief financial officer directly owned 146,001 shares in the company, valued at approximately $9,237,483.27. The trade was a 13.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 612,522 shares of company stock worth $41,600,238 in the last ninety days. Corporate insiders own 27.60% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Concord Wealth Partners increased its position in shares of Tempus AI by 308.0% during the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after purchasing an additional 308 shares during the last quarter. Cherry Tree Wealth Management LLC purchased a new stake in Tempus AI in the 1st quarter worth approximately $31,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Tempus AI in the 1st quarter worth approximately $33,000. Operose Advisors LLC bought a new position in Tempus AI in the 4th quarter worth approximately $25,000. Finally, Bartlett & CO. Wealth Management LLC boosted its stake in Tempus AI by 100.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after purchasing an additional 400 shares during the period. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.